BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, July 12, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: AI co-scientist performs biomedical research ‘at expert level’ in less time
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Nephrology
BioWorld Science, Nephrology
RSS
Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy
Aug. 30, 2017
Roche discloses new DDR1 inhibitors
Aug. 28, 2017
Lilly discovers novel phosphodiesterase PDE1 inhibitors
Aug. 25, 2017
TFAM overexpression rescues sperm defects in infertile mtDNA mutator mice
Aug. 22, 2017
Avadel and Serenity enter into exclusive negotiations for Noctiva
Aug. 18, 2017
Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302
Aug. 11, 2017
FDA grants orphan drug designation for blisibimod as treatment of IgA nephropathy
Aug. 10, 2017
Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease
Aug. 7, 2017
FDA grants orphan drug designation to OMS-721 for IgA nephropathy
Aug. 7, 2017
Quark Pharmaceuticals reports positive results from QPI-1002 phase II study
July 28, 2017
Previous
1
2
…
59
60
61
62
63
64
65
66
67
…
329
330
Next
RSS